Ledger.Open graph →
SEC Form D · filed January 28, 2026

CASI Pharmaceuticals, Inc

Offering
$5.0M
Sold
$5.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
BEIJING, Israel
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Timothy P. Sullivan · Chicago, ILExecMichael J. Dolce · Chicago, ILExecThomas S. Souleles · Chicago, ILDirectorAnnie S. Terry · Chicago, ILDirectorMatthew J. Denison · Chicago, ILExecBrendan J. Barrett · Chicago, ILExecBrandon J. Levitan · Chicago, ILDirectorJonathan C. Cohen · London, United KingdomDirectorSandra Crane · London, United KingdomDirectorAlexander A. Zukiwski · South San Francisco, CAExecWei (Larry) Y. Zhang · South San Francisco, CAExecBarbara A. Krebs-Pohl · South San Francisco, CADirectorJames A. Huang · South San Francisco, CADirectorDavid A. Cory · South San Francisco, CAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗